DHL Supply Chain Has Appointed Noel Singgih and Michael Lai for Asia Pacific Region

SINGAPORE , LELEMUKU.COM - DHL Supply Chain, the world's leading contract logistics provider and a business division under Deutsche Post DHL Group, has appointed Noel Singgih as its Chief Information Officer (CIO) and Michael Lai as Chief Operating Officer (COO) for Asia Pacific. Both Singgih and Lai are industry veterans who have proven track records in their respective areas of expertise and were instrumental in the success of many key initiatives implemented in the organization.

They take over from Steve Walker, who has recently been appointed Chief Executive Officer for the division's regional cluster which includes Thailand, Vietnam, Cambodia and Myanmar. Walker, Singgih and Lai are part of the regional management board.

"DHL Supply Chain has a strong pool of talent in Asia that makes it easy to identify from within the right fits for these roles. Noel has been with us for more than ten years now and his capabilities are evident from the digital projects that he has helped to spearhead in the region, commented Ryan. "I'm equally convinced that Michael's experience in optimizing operations in different international markets, including Greater China, makes him the perfect choice to further enhance our standardization processes, and to derive and drive best practices."

Driving the accelerated digitalization agenda to future-proof our customers' supply chains. Prior to this appointment, Noel Singgih was most recently CIO for Global Service Logistics, E-commerce and Warehousing in DHL Supply Chain. During his tenure, he contributed decisively to the global IT strategy for e-commerce and spearheaded several digital warehouse IT solutions for key customers in the region.

Singgih joined Deutsche Post DHL Group a decade ago as Senior Director for Infrastructure and Service Management. He has held several management positions including CIO for the division's Greater China team from 2016 before taking on the additional role of COO in 2017 to 2019. In this new role, Singgih will continue to report to Markus Voss, CIO & COO DHL Supply Chain and be based out of Singapore.

"The pandemic has demonstrated that it's critical to keep a keen eye on the horizon ahead, and accelerate digital transformation to future-proof our customers' supply chains. I'm honored to be given this opportunity to bring direct impact and influence on deploying the very best digital solutions and innovations for our customers," added Singgih.

Michael Lai was most recently the COO and Head of Solutions and Innovation at SF DHL Supply Chain in China, a role he assumed in 2019 after spearheading the strategic partnership between DHL Supply Chain and SF Holding in Mainland China, Hong Kong and Macau. He was responsible for shaping the operations culture by combining best practices and governance from DHL with local practices. He also actively pursued innovative and digital technologies, implementing various digitalization and data analytics topics to drive operations excellence.

Lai has spent 18 years with DHL where he held senior management roles based out of Taiwan, South China, Macau, Hong Kong and Germany. In 2011, he relocated to Bonn, Germany to work on developing the Deutsche Post DHL Group's global strategy where he earned his chops in managing merger and acquisition projects for the supply chain division.

Lai said, "I'm incredibly honored and excited about this regional role and look forward to meet with our teams to better understand our operations across the multi-cultural cities in Asia to see where I can add value to existing processes and best practices. When it comes to the pursuit of operational excellence, I'm convinced that our laser focus on delivering customer satisfaction will help lead the way in continuous improvement."

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 400,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as "The logistics company for the world".

 DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 66 billion euros in 2020. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. Deutsche Post DHL Group aims to achieve zero-emissions logistics by 2050.(Newswire)

Achiko's Rapid Covid-19 diagnostic Test AptameX Receives Product and Registration Approval from Indonesia'

ZURICH, LELEMUKU.COM - Ad hoc announcement pursuant to Art. 53 LR - Achiko AG through PT Achiko Medika Indonesia, is pleased to announce that the Ministry of Health of the Republic of Indonesia has granted product and registration approval for its proprietary low-cost, rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service, Teman Sehat ("Health Buddy"). Achiko's 50%-subsidiary, PT Achiko Medika Indonesia, and PT Indofarma TBK ("Indofarma) have entered into an agreement to manufacture AptameX and have received product registration approval in Indonesia.

The approval opens the door to the rapid scale-up of production and sale of Achiko's AptameX test kits in Indonesia. Available at an affordable price, AptameX provides millions of Indonesian residents with access to accurate diagnostic testing for Covid-19, enabling the country to more effectively control and contain the pandemic. Indonesia passed 50,000 daily Covid-19 cases in mid-July, amid the spread of the Delta variant in Southeast Asia.

"We are proud and excited to receive the official approval for our breakthrough test kit AptameX. It is an immense achievement for us to be able to market it with Indofarma," said Steven Goh, CEO of Achiko. "At the projected vaccination rate, and considering likely mutations of the virus, the next few years may be very challenging not only for Indonesia, but also quite possibly for the entire world. The combination of AptameX and Teman Sehat provides communities and governments with an affordable, easy-to-use test and a digital passporting service, empowering them in their fight against Covid-19 and all its variants."

Covid-19 poses a challenge to traditional testing methods, as low viral loads evade most rapid tests, calling for a new paradigm. AptameX uses a proprietary, novel chemistry matching the speed of lateral flow rapid tests, while improving on sensitivity. At a significantly lower price point than other tests, it also offers a better user experience. Those that test positive are alerted promptly through the Teman Sehat digital passporting service and asked to follow local guidelines on isolation and quarantine. Its affordability, scalability and superior performance make it an ideal tool in Indonesia's fight against Covid-19.

Indofarma's President Director, Arief Pramuhanto, explains: "Testing regularly is crucial in containing the pandemic. AptameX is a Covid-19 diagnostic test produced domestically by and for the people of Indonesia that has been designed to be integrated into dental hygiene routines. Access to reliable and affordable testing will allow us to lead normal lives again and at the same time work to control the spread of Covid-19. Indofarma, in partnership with Achiko, aims to make this diagnostic readily available at an affordable price for everyone."

Dr Morris S. Berrie, President of Achiko, added: "Our team has been tireless in developing our technologies for rapid, affordable, diagnostic testing for Covid-19 and other forthcoming indications. AptameX is designed to be easy to use and affordable, and therefore accessible to anyone. We believe AptameX and our digital passporting service Teman Sehat will be vital diagnostic resources for many years to come."

In the cooperation between Achiko and Indofarma, a member of Indonesia's Holding BUMN Farmasi, which is partly owned by the Government of the Republic of Indonesia and listed on the Indonesia Stock Exchange (IDX: INAF), Achiko will provide the technology and all materials for diagnostic kits while Indofarma will carry out the production and product registration processes.

Following the Ministry of Health's approval for AptameX Achiko is looking forward to securing a CE mark and introducing AptameX and Teman Sehat swiftly in further countries and regions. In parallel, Achiko is also investigating applications of AptameX to a range of other pathogenic diseases and therapeutic indications.

Achiko, on product approval, has raised a total amount of CHF 3.45 million through share placement at an average price of CHF 0.192 per share to a leading Swiss venture capital group, OCS International Commodities and Investments FZCO and other private investors. The funds are to be used as working capital and production funds as well as for the redemption of the Yorkville convertible note facility from 25 November 2020.

"We're grateful for the support of all our investors and shareholders," said Achiko CEO Goh. "These most recent investments provide a solid platform to consolidate our strategy as a global leading diagnostics company, connecting our capabilities in Europe and Asia in the fight against the challenge of Covid-19." (Newswire)